Ben Derman

No followers

Asst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. https://linktr.ee/bderman

Overview Content 1

Content

See all

Thread by Ben Derman: Results of ALLO-715, an allogeneic BCMA-targeting CAR T cell therapy are published. Novel features to this product: ‼️ Has rituximab kill switch ‼️ Knockout of the T cell receptor alpha constant (TRAC) to reduce GVHD risk ‼️ Knockout CD52 /1 #mmsm w
- Tweet
- Jan 24, 2023
by Ben Derman

Don't miss out curated content from your favorite people

Join to see curated content, recommendations and collections from your favorite people.

Find creators I follow